TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Tonix Pharmaceuticals Holding Corp.

509 Madison Avenue
Suite 306
New York, NY 10022
United States
212-980-9155
http://www.tonixpharma.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees18

Key Executives

NameTitlePayExercisedAge
Dr. Seth Lederman M.D.Co-Founder, Pres, CEO & Chairman472.5kN/A59
Mr. Bradley Saenger CPACFO & Treasurer301.36kN/A43
Dr. Gregory M. Sullivan M.D.Chief Medical Officer & Sec.335kN/A51
Mrs. Jessica Edgar MorrisExec. VP of OperationsN/AN/AN/A
Dr. Ronald R. Notvest Ph.D., MBAExec. VP of Commercial Planning and Devel.N/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Tonix Pharmaceuticals Holding Corp. engages in developing pharmaceutical and biological products to address public health challenges. Its lead product candidate, TNX-102 SL or Tonmya, designed as a bedtime treatment for posttraumatic stress disorder (PTSD), which is in Phase 3 study in the military-related PTSD population. The company is also developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (investigational new drug) application stage, designed as a daytime treatment for posttraumatic stress disorder (PTSD); and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in New York, New York.

Corporate Governance

Tonix Pharmaceuticals Holding Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.